FDA updates, compliance guidance, and practical manufacturing quality resources — written specifically for gummy supplement operations.
FDA's 21 CFR Part 111 is the regulatory baseline for every dietary supplement operation — but gummy manufacturers face specific compliance challenges that generic guidance doesn't address. Here's what matters most for your facility.
Read More →An FDA 483 observation is not a citation — it's an opportunity to demonstrate your quality system is functioning. A well-structured response can prevent escalation to a warning letter. Here's how to approach it.
Read More →Amazon's supplement category requirements have become significantly more rigorous. Understanding exactly what documentation and certifications are required — and in what order to obtain them — can save months of rejected listings.
Read More →NSF/ANSI 455-2 and ISO 22716 serve different markets and purposes. Choosing the wrong one wastes months and resources. This breakdown explains which certification your specific distribution channels require.
Read More →Achieving and documenting active ingredient uniformity in a gummy matrix is fundamentally different from capsule or tablet validation. Here's how to design a validation protocol that satisfies FDA and third-party auditors.
Read More →Independent pharmacy buyers and chain distributor qualification programs require documentation that goes well beyond a standard supplement CoA. This checklist covers every document you'll need to open the pharmacy channel.
Read More →Book a free discovery call with our GMP specialists.
Book Your Free Discovery Call